KAZIA THERAPEUTICS LTD - SPONSORED ADR (KZIA)

Historical Portfolio Holders from Q4 2017 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / SPONSORED ADR
Shares, excl. options Q3 2024
2.13M
Holdings value Q3 2024
$915K
Value change Q3 2024
+$791K
Grand Portfolio weight change Q3 2024
+0%
Number of holders
16
Number of buys Q3 2024
13
Number of sells Q3 2024
-2
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.13M $915K +$791K $0.43 17
2024 Q2 392K $89.5K -$8.32K $0.23 11
2024 Q1 371K $116K -$1.99M $0.31 11
2023 Q4 4.88M $2.15M +$2.05M $0.44 17
2023 Q3 237K $236K -$50.3K $1.00 10
2023 Q2 284K $328K +$11.4K $1.16 9
2023 Q1 271K $279K -$134K $1.03 8
2022 Q4 426K $262K -$39.9K $0.61 9
2022 Q3 481K $527K +$2.17K $1.10 7
2022 Q2 294K $1.24M -$433K $4.20 10
2022 Q1 376K $2.9M -$806K $7.86 10
2021 Q4 476K $4.01M +$166K $8.43 11
2021 Q3 540K $5.03M +$81.3K $11.33 14
2021 Q2 536K $4.34M +$397K $9.87 12
2021 Q1 467K $4.6M -$369K $12.39 12
2020 Q4 529K $3.75M +$1.08M $8.64 13
2020 Q3 442K $2.31M +$888K $6.75 10
2020 Q2 310K $723K +$170K $3.35 6
2020 Q1 261K $472K +$31.2K $2.90 6
2019 Q4 250K $670K -$8.53K $4.34 7
2019 Q3 253K $568K +$72.9K $3.75 7
2019 Q2 227K $324K +$52K $2.42 7
2019 Q1 205K $365K -$27.5K $3.34 5
2018 Q4 217K $293K -$12.9K $2.39 6
2018 Q3 221K $400K +$60.5K $3.24 8
2018 Q2 111K $1.75M +$33.4K $2.97 7
2018 Q1 94.7K $531K +$56.8K $5.61 6
2017 Q4 84.6K $269K +$269K $3.19 4